n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, August 12th, 2016

The QualityStocks
Daily Stock List

graphic
graphic

SpendSmart Networks, Inc. (SSPC)

Marketbeat and Flagler Financial Group reported on SpendSmart Networks, Inc. (SSPC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Founded in 2007, SpendSmart Networks, Inc. does business as SMS Masterminds (SMS). The Company provides proprietary loyalty systems and a collection of digital engagement and marketing services. These help local merchants build relationships with consumers and grow revenues. SpendSmart’s plan is to expand on its existing markets and also go after new markets with strong product and service offerings. SpendSmart Networks is based in San Luis Obispo, California. The Company formerly went by the name The SpendSmart Payments Company, Inc. It changed its name to SpendSmart Networks, Inc. in June 2014.

SpendSmart Networks delivers and manages loyalty platforms. These include merchant funded rewards, loyalty rewards tablet/kiosk, and proprietary rewards management systems. In addition, the Company delivers and manages mobile marketing technology, including text and email messaging, customer analytics and propensity marketing, patent pending automated engagement engine, and Text2Win sweepstakes features.

Furthermore, SpendSmart Networks delivers and manages enterprise level loyalty and mobile marketing consulting consisting of monthly hands on reviews by its Certified Masterminds, campaign creation and optimization, and localized support. The Company also provides mobile and loyalty marketing services for small and medium sized businesses; personalized Website, e-commerce, and mobile app development services; and also Web marketing tools and analytics.

SpendSmart Networks is concentrating on the growing mobile advertising market. Currently, SpendSmart supports about 4.8 million mobile based subscribers in its service network of Small Merchant Businesses (SMB's) throughout North America.

Its services are implemented and supported by a wide-ranging network of certified digital marketing specialists (the above-mentioned Certified Masterminds) who build revenue and consumer relationships for merchants via loyalty programs, mobile marketing, as well as website development. Consumers' dollars go further when they spend it with merchants in the SpendSmart network of merchants. This is because consumers receive exclusive deals, earn rewards, and ultimately build a connection with their favorite merchants.

Yesterday, SpendSmart Networks (dba SMS Masterminds) announced its partnership with Sprint and Samsung to provide 3G-enabled tablets to small businesses for use with its unique mobile marketing services. SMS Masterminds is improving its proprietary loyalty platform with upgraded technology through a partnership with Sprint using Samsung tablets. SMS Masterminds has in excess of 5,000 small businesses using its services. Its cloud-based marketing platform includes a loyalty check-in system, which uses a customer's mobile number to reward them for visits. This eliminates less efficient loyalty punch cards, apps, as well as key fobs.

SpendSmart Networks, Inc. (SSPC), closed Friday's trading session at $0.05656, up 34.35%, on 3,500 volume with 2 trades. The average volume for the last 60 days is 13,679 and the stock's 52-week low/high is $0.0301/$0.65.

Quantum Materials Corp. (QTMM)

Stock News Now, SmallCapVoice, and TopPennyStockMovers reported earlier on Quantum Materials Corp. (QTMM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Quantum Materials Corp. manufactures Tetrapod Quantum Dots for use in medical, display, solar energy, and lighting applications via its patent-pending volume production process. Tetrapod Quantum Dot semiconductors allow for a new level of engineered performance for consumer and industrial products. Quantum Materials has its wholly-owned subsidiary, Solterra Renewable Technologies, Inc. Solterra develops sustainable quantum dot solar technology.  Quantum Materials is based in San Marcos, Texas.

Quantum dots fall into the category of nanocrystals. This also includes quantum rods and nanowires. Quantum Dots measure near one billionth of an inch. They are a non-traditional type of semiconductor. They can be used as an enabling material across numerous industries. They have first-rate versatility and are flexible in form.  

Solterra Renewable Technologies develops sustainable solar technology through replacing silicon wafer-based solar cells with high-production, low-cost, efficient and flexible thin-film quantum dot solar cells. Solterra’s objective is to market a thin-film photovoltaic cell incorporating its proprietary quantum dot semiconductors.    

Solterra will use Quantum Materials’ exclusive license from University of Arizona Regents for Dr. Ghassan Jabbour’s patented printing technology in the production of its solar cells. Solterra’s goal is to become the first solar cell manufacturer that can provide a solar electricity solution, which competes on a non-subsidized basis with the price of retail electricity in the above-mentioned key markets.

Quantum Materials has secured 3D printing and additive manufacturing anti-counterfeiting quantum dot detection technology. This was developed at the Institute for Critical Technology and Applied Science and the Design, Research, and Education for Additive Manufacturing Systems (DREAMS) Laboratory at Virginia Tech. This technology embeds quantum dots within objects being 3D printed to produce an innovative, physically uncloneable signature known only to the object's manufacturer.

Quantum Materials has launched its new QDX™ class of high-stability Cadmium-free quantum dots. QDX™ Quantum Dots do not degrade under the high heats used in application to film, silicon, and polymer. They allow for creative LCD display and LED lighting engineering and lowering protective barrier film costs.

This month, Quantum Materials announced that it has partnered with a Texas-based E&P technology business. Quantum is presently developing specialized nanomaterials for use in oil and gas well production optimization. The project is nearing the completion of the initial phase. The project is targeting new materials that are expected to provide for safer and more efficient recovery of hydrocarbon resources.

Quantum Materials Corp. (QTMM), closed Friday's trading session at $0.1165, down 0.43%, on 464,000 volume with 54 trades. The average volume for the last 60 days is 201,071 and the stock's 52-week low/high is $0.085/$0.20.

True Nature Holding, Inc. (TNTY)

Real Pennies reported earlier on True Nature Holding, Inc. (TNTY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

True Nature Holding, Inc.’s business plan considers a roll-up of businesses in the compounding pharmacy industry. The plan contemplates numerous acquisitions of businesses that have conventionally operated locally, but that have specialty formulations, which may have a larger market. The Company is targeting the acquisition of pharmacies that serve the human, and in some instances, pet markets. True Nature Holding has its corporate headquarters in Atlanta, Georgia. The Company’s shares trade on the OTC Bulletin Board.

True Nature’s intention is to acquire many pharmacies throughout the United States to attain its goals. Its planned objective is establishing a national online pharmacy, True Nature Pharmacy, which will be a wholly-owned subsidiary. True Nature Pharmacy will sell its product mix nationally through online marketing distribution channels.

True Nature’s plan is to acquire a series of businesses that specialize in compounding pharmacy activities, chiefly direct to consumers, and to doctors and veterinary professionals. Pharmaceutical compounding is performed in compounding pharmacies. It is the creation of a specific pharmaceutical product to fit the exclusive need of a patient. To perform this, compounding pharmacists combine or process suitable ingredients by means of different tools.

True Nature Holding has acquired 100 percent of the membership interests of Newco4pharmacy, LLC. Newco4pharmacy is a development stage business targeted at establishing a network of compounding pharmacies.

In March of this year, True Nature Holding released an update on its plans to acquire a network of compounding pharmacy businesses. The plans include a regional and national presence, across many product lines.

True Nature’s plan is to develop regionally, with operations in Florida, then moving north to the State of Georgia, consolidating a solid presence in the Southeast. The Company is creating a blend of human and veterinary businesses, and also a balance of cash oriented operations, and more usual insurance based operations.

This week, True Nature Holding announced another update on its acquisition program. Mr. Jim Driscoll, True Nature Holding’s Chief Executive Officer, said, "Over the past month we have, through our ongoing outreach and evaluation, identified several highly attractive new acquisition candidates, each of which provides added momentum toward our goal of creating a national platform of compounding pharmacies. Consequently, we are planning to pursue three acquisitions where we have signed letters of intent. Assuming the successful completion of these deals, when combined, these will give us coverage in over 40 states, as well as expand our portfolio with quality products that can be distributed across our network."

True Nature Holding, Inc. (TNTY), closed Friday's trading session at $0.35, down 12.50%, on 8,500 volume with 2 trades. The average volume for the last 60 days is 15,367 and the stock's 52-week low/high is $0.32/$3.48.

Inspyr Therapeutics, Inc. (NSPX)

We are reporting on Inspyr Therapeutics, Inc. (NSPX) today, here at the QualityStocks Daily Newsletter.

Inspyr Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in San Antonio, Texas. It is developing novel prodrug therapeutics for the treatment of cancer. Mipsagargin is the Company’s lead agent. It is in human clinical trials for patients with several different tumor types. Inspyr Therapeutics’ team has substantial pharmaceutical industry and scientific experience. The Company lists on the OTC Markets Group’s OTCQB.

The Company is developing a novel technology platform. It combines a powerful cytotoxin (thapsigargin) with a patented prodrug delivery system, which targets the release of drugs within solid tumors without the side effects of chemotherapeutic agents. The innovative platform technology has the potential to work across a spectrum of drugs, which precisely target different cancers.

The above-mentioned Mipsagargin (G-202) is a prodrug in human clinical trials for patients with hepatocellular carcinoma (HCC, or liver cancer), glioblastoma (GBM, or brain cancer) and prostate cancer.

Mipsagargin has been studied in a Phase 2 clinical trial in patients with hepatocellular carcinoma (liver cancer) and has been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in this indication. At present, Mipsagargin is undergoing evaluation in an open-label, single-arm, Phase II clinical study in patients with glioblastoma (brain cancer). Furthermore, it is undergoing evaluation in two Phase II clinical pilot studies in patients with prostate and clear cell renal cancer.

Last week, Inspyr Therapeutics announced that Mr. Christopher Lowe was appointed President and Chief Executive Officer (CEO), and as a member of Inspyr’s Board of Directors. Mr. Lowe has over 15 years of executive management experience in life sciences as CEO, Chief Financial Officer, and Chief Business Officer. He has been an advisor to Inspyr Therapeutics’ Board of Directors since March of this year.

Moreover, this week, Inspyr Therapeutics announced the appointment of Ronald Shazer, M.D. as Senior Vice President and Chief Medical Officer (CMO), effective immediately. Dr. Shazer will lead the clinical development of Mipsagargin. He most recently was CMO of Tracon Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted therapeutics for cancer. Dr. Shazer previously was Senior Director, Clinical Lead Oncology at Pfizer.

Inspyr Therapeutics, Inc. (NSPX), closed Friday's trading session at $0.16, even for the day, on 17,612 volume with 5 trades. The average volume for the last 60 days is 13,886 and the stock's 52-week low/high is $0.101/$0.9372.

Spotlight Innovation, Inc. (STLT)

Ceocast News, TopPennyStockMovers, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Spotlight Innovation, Inc. identifies and acquires rights to innovative and proprietary platform technology candidates. The OTCQB-listed Company’s focus is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and unique opportunities. Spotlight Innovation provides solutions for healthcare-focused companies commercializing healthcare intellectual property (IP). The Company is headquartered in West Des Moines, Iowa.

Spotlight Innovation’s business mission is to profoundly impact patient health via advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates is realized through its extensive relationships with many leading academic institutions and other sources. The Company provides value-added development capability and funding to accelerate development progress.

It will partner with proven market leaders through sale, out-license, or strategic alliance, when commercially significant benchmarks have been reached. Spotlight Innovation works to acquire the rights, through acquisition, license, or otherwise, to unique and proprietary Platform Technology Candidates. Furthermore, it works to provide value-added development capability and funding to achieve fast IND approval to begin human clinicals for targeted Platform Technology Candidates.

Spotlight Innovation also works to commercialize, for each Platform Technology Candidate, one or multiple indications through sale, out-license, or strategic relationships/marketing agreements. This is while continuing to retain, where practical, rights/fields of use to other indications for future commercialization.

Spotlight Innovation has retained distinguished French oncologist Mr. David Khayat, MD, PhD, FASCO, as the Principal Investigator for a European Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. The clinical study will take place at Pitié-Salpêtrière Hospital in Paris, France. Crotoxin is one of several proprietary compounds, owned by Spotlight Innovation, derived from snake venom.

Recently, Spotlight Innovation announced that it finalized plans for entering into an agreement with Maitland Labs (Orlando, Florida) to establish its drug production and product development facilities at Maitland Lab's sterile fill drug production plant, now being built. The facility is scheduled to be operational next month, and will be Food and Drug Administration (FDA) registered and compliant with Good Manufacturing Practice standards. Additionally, Spotlight will use the facility to produce products for use in pre-clinical testing and for its clinical trials.

Last month, Spotlight Innovation announced that Dr. Geoffrey Laff, Ph.D., joined the Company in the new position of Vice President of Scientific Strategy. Dr. Laff will oversee the development and implementation of Spotlight's scientific research and development (R&D) strategy, assist in the exploration and analysis of new acquisition opportunities, as well as contribute to clinical management activities.

Spotlight Innovation, Inc. (STLT), closed Friday's trading session at $0.35, down 6.67%, on 2,500 volume with 1 trade. The average volume for the last 60 days is 2,759 and the stock's 52-week low/high is $0.335/$1.22.

graphic

The QualityStocks
Company Corner

graphic
graphic

Giggles N' Hugs, Inc. (GIGL)

The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.05591, up 86.37%, on 113,702 volume with 8 trades. The stock’s average daily volume over the past 60 days is 65,082, and its 52-week low/high is $0.0137/$0.25.

Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.

In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.

Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.

Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.

Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer

Giggles N' Hugs, Inc. Company Blog

Giggles N' Hugs, Inc. News:

Giggles N’ Hugs, Inc. (GIGL) engages Kiddos, Inc. and Michelle Steinberg of dOMAIN Integrated to Launch New Marketing and PR Initiatives

Repeat: Giggles N Hugs to present at the 9th annual LD Micro Conference main event

Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $1.90, up 3.65%, on 4,565 volume with 8 trades. The stock’s average daily volume over the past 60 days is 3,823, and its 52-week low/high is $1.50/$6.95.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Successful Cell Transplantation for the First Patient in Phase 1 Clinical Trial of ISC-hpNSC

International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease

eXp World Holdings, Inc. (EXPI)

The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $2.94, up 2.44%, on 15,612 volume with 22 trades. The stock’s average daily volume over the past 60 days is 8,300, and its 52-week low/high is $0.51/$3.15.

eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.

Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.

Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.

Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer

eXp World Holdings, Inc. Company Blog

eXp World Holdings, Inc. News:

eXp Realty Reaches 1,500 Agent Mark, Up 73% From 864 at Beginning of 2016

Russ Cofano Joins eXp World Holdings and eXp Realty

Rick Miller and Randall Miles Join eXp World Holdings Board of Directors

Moxian, Inc. (MOXC)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $6.054, up 0.90%, on 9,450 volume with 35 trades. The stock’s average daily volume over the past 60 days is 6,665, and its 52-week low/high is $1.10/$5.00.

Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data

Moxian Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate

Moxian, Inc. Covered by Crystal Equity Research

FlexWeek (FXWK)

The QualityStocks Daily Newsletter would like to spotlight FlexWeek (FXWK). Today, FlexWeek closed trading at $0.555, even for the day. The stock’s average daily volume over the past 60 days is 43, and its 52-week low/high is $0.075/$1.15.

FlexWeek (FXWK) is a pioneer in the global peer-to-peer (P2P) marketplace with the introduction of a unique platform that allows timeshare owners to discover, book and offer unused vacation time directly to the public and other timeshare owners. This approach eliminates the need for timeshare owners to use costly trading platforms such as Interval International or RCI, while potentially reducing unused timeshare inventory.

FlexWeek's P2P website (www.FlexWeek.com) and mobile application is similar to AirBNB's $20 billion approach to the travel industry, but is the first and only P2P marketplace exclusive to fractional vacation ownerships. FlexWeek differs from the existing model, where timeshare weeks must be "banked" with a trading company such as Interval International or RCI, and instead charges the booking fees to the renter of the vacation time, eliminating the cost to the private timeshare owner.

The FlexWeek platform also addresses another specific industry challenge. The average timeshare is only booked 79% of the year, according to the American Resort Development Association's 2012 research survey. Whether or not a privately owned timeshare unit is used, the owner still has to pay annual maintenance fees, and most owners end up losing thousands of dollars in wasted paid-for vacation time over their ownership period. With FlexWeek, an owner of unused paid vacation time can now offer their specific booked week for rent directly to the FlexWeek marketplace to recoup cost or even make a profit on the rental. The glut of unused timeshare inventory allows a potential renter to stay in a very nice condo for a fraction of what they would pay in hotel fees making it a win-win for both the owner and the renter of the vacation time.

Led by founder Kristopher Chavez, who has more than 10 years of experience operating businesses that acquire, rent, sell and transfer timeshares internationally, FlexWeek's management team will leverage its collective expertise to facilitate the company's direction and growth in this new market. FlexWeek's leadership has founded rapidly growing sales organizations generating 8-figure revenues within a year's time, and has experience scaling other models to financial success and/or acquisition rapidly with limited investment. Disclaimer

FlexWeek Company Blog

FlexWeek News:

FlexWeek, Inc. (FXWK): Stay in Vacation Homes around the World for Less than the Cost of Hotels

FlexWeek, Inc. (FXWK) Announces Engagement of QualityStocks Corporate Communications Suite

FlexWeek, Inc. (FXWK) is “One to Watch”

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Profitable Trader Authority
(QKLS)

2.

QualityStocks
(GIGL)

3.

StreetInsider
(ACIA)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251